U.S. warns Novartis on Alzheimer's drug promotion (Reuters via Yahoo! News)
A Novartis AG promotion for Alzheimer's drug Exelon made misleading claims about the medicine's effectiveness and risks, U.S. health officials warned the company in a letter released on Tuesday.

FDA approves Abraxis's cefotetan disodium for injection (Pharmaceutical Business Review)
Abraxis Pharmaceutical Products has received FDA approval to market cefotetan disodium for injection, the generic equivalent of AstraZenecas anti-infective Cefotan.

QUMAS R&D Suite Selected By SQI Diagnostics For Automated Compliance Solution (PharmaceuticalOnline)
QUMAS, a leading provider of quality management and regulatory affairs solutions, recently announced that SQI Diagnostics Inc., a medical systems automation company focused on evolving laboratory-based biomarker testing, has selected the QUMAS R&D Suite as its compliance solution for content and submissions management.